首页> Antimicrobial agents and chemotherapy.> A Second-Generation Fungerp Analog, SCY-247, Shows Potent In Vitro Activity against Candida auris and Other Clinically Relevant Fungal Isolates

A Second-Generation Fungerp Analog, SCY-247, Shows Potent In Vitro Activity against Candida auris and Other Clinically Relevant Fungal Isolates

导出原文传递

翻译打印收藏纠错

第一作者： Chu, Sherman

作者： Chu, Sherman ^[1] ; Long, Lisa ^[2] ; Sherif, Rania ; McCormick, Thomas S. ; Borroto-Esoda, Katyna ; Barat, Stephen ; Ghannoum, Mahmoud A.

作者单位： Scynexis Inc, Jersey City, NJ USA ^[1] Case Western Reserve Univ, Dept Dermatol, Cleveland, OH 44106 USA ^[2]

关键词 Ibrexafungerp candidiasis beta-(1 3)-D-glucan fungerps triterpenoid class

发布时间 2021-04-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Antimicrobial agents and chemotherapy.

2021年65卷3期

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

A Second-Generation Fungerp Analog, SCY-247, Shows Potent In Vitro Activity against Candida auris and Other Clinically Relevant Fungal Isolates

Antimicrobial agents and chemotherapy.

相似文献

同项目论文

Antimicrobial agents and chemotherapy.

相关期刊

检索历史 清除

A Second-Generation Fungerp Analog, SCY-247, Shows Potent In Vitro Activity against Candida auris and Other Clinically Relevant Fungal Isolates

Antimicrobial agents and chemotherapy.

相似文献

同项目论文

Antimicrobial agents and chemotherapy.

相关期刊

检索历史清除